AI Articles and Analysis in Pharma

AstraZeneca is a global biopharmaceutical company that researches, develops, manufactures, and markets prescription drugs and vaccines. Its key therapeutic areas include oncology, cardiovascular, renal, metabolism, respiratory, and immunology. In 2022, the company reported revenue of $42.67 billion and a profit of $4.08 billion. The company has a significant global presence, employing around 89,900 people across more than 60 countries as of 2023.

As stakeholders in the life sciences and healthcare industries rush to adopt GenAI and integrate it into their projects and processes, they are walking a tightrope. GenAI will play a vital role in the future of healthcare in ways that we can hardly yet imagine; on the other hand, concerns like patient data privacy and potential inaccuracies have led many to take a cautious approach. 

According to research from the American Society for Biochemistry and Molecular Biology, nine out of 10 drugs fail to make it to market in the clinical trials process. Researchers in the cited studies found that 40-50% of these failures are due to a lack of clinical efficacy, meaning that the drug is not able to produce its intended effect in people, and 30% were due to unmanageable toxicity or side effects.

The applications of AI in the healthcare and life sciences industries are vast, with data-powered algorithms and analytics promising to upend the status quo. Applications, including the use of AI to interpret medical imaging, optimize drug discovery and development, analyze large-scale data sets to identify patterns among patient populations, and streamline provider workflows, are already transforming the industry. 

Far beyond surface-level 'chatbot' software, and other customer-facing support systems, the same generative AI (GenAI) capabilities having direct impacts across language workflows in front-office tasks in financial and legal services is also having a direct impact on how research teams in the life sciences space are targeting solutions for rare diseases and novel treatments. 

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

Dell Technologies Inc., or simply 'Dell', is a Texas-based multinational technology company. Dell is predominantly known for its personal computing products, particularly its desktops, laptops, and workstations. Gradually, the company branched out into other product and service offerings, including network equipment, software and cloud solutions, and automation services.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.